Hany Mohamed El Hennawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hany Mohamed El Hennawy has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
Omar Safar
Urology Department, Armed Forces Hospitals, Khamis Mushayte, Saudi Arabia
26 shared publicationsAbdullah S. Al Faifi
Surgery Department, Section of Transplantation, Armed Forces Hospitals, Khamis Mushayte, Saudi Arabia
19 shared publicationsMohammad F. Zaitoun
Pharmacy Department, Pharmaceutical Care, Diaverum Saudi Arabia, Riyadh, Saudi Arabia
17 shared publicationsAhmed Mahedy
Nephrology Department, Armed Forces Hospitals Southern Region, Khamis Mushayte, Saudi Arabia
11 shared publicationsEisa Al Atta
Surgery Department, Section of Transplantation, Armed Forces Hospitals Southern Region, Khamis Mushayte, Saudi Arabia
11 shared publicationsWeam El Nazer
Nephrology Department, Armed Forces Hospitals, Southern Region, Khamis Mushayte, Saudi Arabia
9 shared publications
Latest Publications
- 17 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Bladder Management in Pediatric Kidney Transplantation: A Narrative Systematic Review With a Hypothesis‐Generating Phenotype Framework
Congenital anomalies of the kidney and urinary tract cause 30%–50% of pediatric end‐stage renal disease, and roughly one‐third of affected children have clinically significant lower urinary tract dysfunction (LUTD). Transplanting into a dysfunctional bladder increases the risks of infection, graft pyelonephritis, and graft loss; however, there is no consensus on clinical objectives, catheterization and augmentation practices vary across centers, and no validated bladder‐specific risk score has been established. Following PRISMA 2020, we searched PubMed, Embase, and the Cochrane Library (2000–2025) for studies of pediatric kidney transplant recipients (≤ 18 years) that reported graft, urologic, or infectious outcomes related to bladder function. Two reviewers screened studies and extracted data, and risk of bias was assessed with the Newcastle‐Ottawa Scale. Fifty‐two studies met the inclusion criteria, including 10 retrospective cohort studies with 428 children. Because comparable cohorts were few and outcome definitions were heterogeneous, the evidence was synthesized narratively, with quantitative pooling limited to graft survival in five cohorts. Pooled graft survival in recipients with LUTD was 83.8% (95% CI 75.6%–89.7%; I 2 = 28%; moderate certainty), and the available comparisons showed no significant difference in graft survival between recipients with LUTD and those with normal bladders. Urologic complication and urinary tract infection (UTI) rates varied primarily with follow‐up duration rather than with underlying pathology alone. Seven risk factors were associated with adverse outcomes; children with three or more factors had higher UTI rates and lower 5‐year graft survival than those with fewer factors. Clean intermittent catheterization and Mitrofanoff procedures were associated with better long‐term graft survival despite higher UTI rates. We propose classifying LUTD into four phenotypes according to the dominant injury mechanism: low compliance with high pressure, poor emptying, isolated detrusor overactivity, and mixed dysfunction. This framework is hypothesis‐generating and requires prospective validation. Overall certainty of evidence is low to moderate; consensus definitions, registry harmonization, and prospective validation of phenotype‐based algorithms should take priority over the publication of further unvalidated risk scores. Trial Registration: PROSPERO: CRD420261416509
- 17 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Bladder Management in Pediatric Kidney Transplantation: A Narrative Systematic Review With a Hypothesis‐Generating Phenotype Framework
Congenital anomalies of the kidney and urinary tract cause 30%–50% of pediatric end‐stage renal disease, and roughly one‐third of affected children have clinically significant lower urinary tract dysfunction (LUTD). Transplanting into a dysfunctional bladder increases the risks of infection, graft pyelonephritis, and graft loss; however, there is no consensus on clinical objectives, catheterization and augmentation practices vary across centers, and no validated bladder‐specific risk score has been established. Following PRISMA 2020, we searched PubMed, Embase, and the Cochrane Library (2000–2025) for studies of pediatric kidney transplant recipients (≤ 18 years) that reported graft, urologic, or infectious outcomes related to bladder function. Two reviewers screened studies and extracted data, and risk of bias was assessed with the Newcastle‐Ottawa Scale. Fifty‐two studies met the inclusion criteria, including 10 retrospective cohort studies with 428 children. Because comparable cohorts were few and outcome definitions were heterogeneous, the evidence was synthesized narratively, with quantitative pooling limited to graft survival in five cohorts. Pooled graft survival in recipients with LUTD was 83.8% (95% CI 75.6%–89.7%; I 2 = 28%; moderate certainty), and the available comparisons showed no significant difference in graft survival between recipients with LUTD and those with normal bladders. Urologic complication and urinary tract infection (UTI) rates varied primarily with follow‐up duration rather than with underlying pathology alone. Seven risk factors were associated with adverse outcomes; children with three or more factors had higher UTI rates and lower 5‐year graft survival than those with fewer factors. Clean intermittent catheterization and Mitrofanoff procedures were associated with better long‐term graft survival despite higher UTI rates. We propose classifying LUTD into four phenotypes according to the dominant injury mechanism: low compliance with high pressure, poor emptying, isolated detrusor overactivity, and mixed dysfunction. This framework is hypothesis‐generating and requires prospective validation. Overall certainty of evidence is low to moderate; consensus definitions, registry harmonization, and prospective validation of phenotype‐based algorithms should take priority over the publication of further unvalidated risk scores. Trial Registration: PROSPERO: CRD420261416509
- Open Access
- 23 June 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Cytomegalovirus and BK polyomavirus in belatacept-treated kidney transplant recipients: a systematic review and meta-analysis
This systematic review and meta-analysis evaluated the risk of cytomegalovirus (CMV) and BK virus infections in kidney transplant recipients receiving belatacept-based immunosuppression compared to calcineurin inhibitor (CNI)-based regimens. Seven studies (six randomized controlled trials and one cohort study) involving 1,625 patients were analyzed. Pooled results showed little to no evidence of a difference in CMV infection risk between belatacept and CNI-treated patients (odds ratio [OR] 1.24, 95% confidence interval [CI] 0.80-1.94; P = 0.34). However, there was little to no evidence of a difference in BK virus infection risk, though the point estimate suggested a possible increase (OR 2.11, 95% CI 0.71-6.33, P = 0.18). Heterogeneity was low across studies (I² = 0%). A sensitivity analysis excluding the single non-randomized cohort study (i.e., restricted to the randomized controlled trials) showed little to no evidence of a difference in CMV infection risk (OR 1.16, 95% CI 0.57-2.37; P = 0.69). While belatacept offers renal and metabolic advantages over CNIs, the potential for CMV and BK viremia necessitates careful monitoring, particularly in high-risk patients. Standardized viral surveillance and further research in larger cohorts are needed to clarify long-term infection risks.
- 23 June 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Open AccessCytomegalovirus and BK polyomavirus in belatacept-treated kidney transplant recipients: a systematic review and meta-analysis
This systematic review and meta-analysis evaluated the risk of cytomegalovirus (CMV) and BK virus infections in kidney transplant recipients receiving belatacept-based immunosuppression compared to calcineurin inhibitor (CNI)-based regimens. Seven studies (six randomized controlled trials and one cohort study) involving 1,625 patients were analyzed. Pooled results showed little to no evidence of a difference in CMV infection risk between belatacept and CNI-treated patients (odds ratio [OR] 1.24, 95% confidence interval [CI] 0.80-1.94; P = 0.34). However, there was little to no evidence of a difference in BK virus infection risk, though the point estimate suggested a possible increase (OR 2.11, 95% CI 0.71-6.33, P = 0.18). Heterogeneity was low across studies (I² = 0%). A sensitivity analysis excluding the single non-randomized cohort study (i.e., restricted to the randomized controlled trials) showed little to no evidence of a difference in CMV infection risk (OR 1.16, 95% CI 0.57-2.37; P = 0.69). While belatacept offers renal and metabolic advantages over CNIs, the potential for CMV and BK viremia necessitates careful monitoring, particularly in high-risk patients. Standardized viral surveillance and further research in larger cohorts are needed to clarify long-term infection risks.
- 11 June 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (6) , 973-985
Preventive Dental Strategies to Minimize Oral Health Complications After Renal Transplantation: A Systematic Review
- 11 June 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (6) , 973-985
Preventive Dental Strategies to Minimize Oral Health Complications After Renal Transplantation: A Systematic Review
- 10 June 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (6) , 1027-1034
The Economic Imperative of Living Donor Kidney Transplantation: A Single-Center Micro-Cost Analysis for Sustainable ESRD Care in Saudi Arabia
- 10 June 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (6) , 1027-1034
The Economic Imperative of Living Donor Kidney Transplantation: A Single-Center Micro-Cost Analysis for Sustainable ESRD Care in Saudi Arabia
- 1 April 2026
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 24 (4) , 308-314
Risk Factors and Outcomes of Bowel Complications in Single-Site Donor Nephrectomy: A Retrospective Analysis of 350 Consecutive Cases
This study evaluated the incidence, risk factors, and management of bowel complications in a consecutive series of laparoendoscopic single -site donor nephrectomy procedures. A retrospective analysis was performed on 350 consecutive laparoendoscopic single -site donor nephrectomy cases (68 % male donors ; mean age 31.5 ± 8.2 years; mean body mass index 26.1 ± 4.8 ; 8.6 % with prior abdominal surgery ) seen from September 2017 through July 2025 at a high -volume center. The bowel complication rate was 1.14 % (4 of 350 ). Etiologies included internal herniation (n = 1 ), adhesive obstruction (n = 1 ), obstruction postserosal repair (n = 1 ), and bowel perforation (n = 1 ). All cases required surgical management, including 3 bowel resections and 1 laparoscopic defect closure. The 4 affected donors had a higher mean age (40.1 ±3.9 years ) and mean body mass index (33.7 ± 1.9 ), and 50 % had received prior abdominal surgery, both of which significantly exceeded the cohort baseline. No complications stemmed from initial port insertion or thermal injury. The overall 30 -day readmission rate was 2.28 %, and the recipient 1 -year graft survival rate was 97.3 %. Bowel complications following laparoendoscopic single -site donor nephrectomy are rare but clinically significant, predominantly presenting postoperatively and requiring surgical intervention. High body mass index and a history of abdominal surgery are key associated risk factors. Meticulous surgical technique remains paramount to minimize risk. Therefore, meticulous surgical technique and careful patient selection, particularly in donors with obesity or prior abdominal surgery, are more critical to bowel safety than the choice of a minimally invasive approach.
- 1 April 2026
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 24 (4) , 308-314
Risk Factors and Outcomes of Bowel Complications in Single-Site Donor Nephrectomy: A Retrospective Analysis of 350 Consecutive Cases
This study evaluated the incidence, risk factors, and management of bowel complications in a consecutive series of laparoendoscopic single -site donor nephrectomy procedures. A retrospective analysis was performed on 350 consecutive laparoendoscopic single -site donor nephrectomy cases (68 % male donors ; mean age 31.5 ± 8.2 years; mean body mass index 26.1 ± 4.8 ; 8.6 % with prior abdominal surgery ) seen from September 2017 through July 2025 at a high -volume center. The bowel complication rate was 1.14 % (4 of 350 ). Etiologies included internal herniation (n = 1 ), adhesive obstruction (n = 1 ), obstruction postserosal repair (n = 1 ), and bowel perforation (n = 1 ). All cases required surgical management, including 3 bowel resections and 1 laparoscopic defect closure. The 4 affected donors had a higher mean age (40.1 ±3.9 years ) and mean body mass index (33.7 ± 1.9 ), and 50 % had received prior abdominal surgery, both of which significantly exceeded the cohort baseline. No complications stemmed from initial port insertion or thermal injury. The overall 30 -day readmission rate was 2.28 %, and the recipient 1 -year graft survival rate was 97.3 %. Bowel complications following laparoendoscopic single -site donor nephrectomy are rare but clinically significant, predominantly presenting postoperatively and requiring surgical intervention. High body mass index and a history of abdominal surgery are key associated risk factors. Meticulous surgical technique remains paramount to minimize risk. Therefore, meticulous surgical technique and careful patient selection, particularly in donors with obesity or prior abdominal surgery, are more critical to bowel safety than the choice of a minimally invasive approach.
- 6 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 113
Incisional hernia after kidney transplantation: a systematic review and proposal of a peri-transplant risk scoring system for tailored preventive surgical planning
- 6 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 113
Incisional hernia after kidney transplantation: a systematic review and proposal of a peri-transplant risk scoring system for tailored preventive surgical planning
- 5 March 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (3) , 488-499
Optimizing Renal Allograft Dysfunction Management: A Systematic Review and Proposed Algorithm for Interventional Radiology Versus Surgical Interventions
- 5 March 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (3) , 488-499
Optimizing Renal Allograft Dysfunction Management: A Systematic Review and Proposed Algorithm for Interventional Radiology Versus Surgical Interventions
- 1 March 2026
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 24 (3) , 199-209
The Simplified Pregnancy Risk Score (SPRS): Personalized Preeclampsia Risk Stratification for Living Kidney Donors
Pregnancy after living kidney donation is associated with increased risk of preeclampsia and other hypertensive disorders; however, clinical practice and a standardized approach remain unclear. We performed a systematic review and meta-analysis to provide updated risk estimates for adverse pregnancy outcomes after living kidney donation, to allow development and preliminary assessment of the Simplified Pregnancy Risk Score, a structured framework for individualized risk stratification. We followed PRISMA guidelines and searched PubMed, Scopus, Web of Science, and the Cochrane Library through August 2023 to include studies on maternal and fetal outcomes in pregnancies after living kidney donation. We used random-effects models to pool odds ratios and calculate absolute risk differences. We used subgroup and regression analyses to identify key risk modifiers that informed the development of the points-based Simplified Pregnancy Risk Score. Our search identified 15 studies encompassing 4200 pregnancies. Preeclampsia (pooled incidence 7.2%; odds ratio = 2.86; 95% CI, 1.62-5.05; absolute risk difference +4.7% ) and gestational hypertension (odds ratio = 2.53, 95% CI, 1.11-5.74)were significantly increased in donors compared with nondonors. Risk of preterm birth was modestly increased (odds ratio = 1.32; 95% CI, 1.01-1.74). Subgroup analyses identified clinically relevant effect modifiers: donors aged ≥35 years had higher odds of preeclampsia than younger donors, and a donation-to-conception interval of <2 years was associated with increased risk of preterm birth. The Simplified Pregnancy Risk Score integrated 8 evidence-based factors into a simple points-based system, categorizing donors as low (0-2 points), moderate (3-5 points), or high risk (≥6 points). The Simplified Pregnancy Risk Score represents the first structured, evidence-informed framework designed to support individualized pre-conception counseling and risk-aware antenatal management in kidney donors. Although formal validation is required, this system addresses a critical translational gap by converting population-level evidence into actionable clinical risk stratification.
- 1 March 2026
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 24 (3) , 199-209
The Simplified Pregnancy Risk Score (SPRS): Personalized Preeclampsia Risk Stratification for Living Kidney Donors
Pregnancy after living kidney donation is associated with increased risk of preeclampsia and other hypertensive disorders; however, clinical practice and a standardized approach remain unclear. We performed a systematic review and meta-analysis to provide updated risk estimates for adverse pregnancy outcomes after living kidney donation, to allow development and preliminary assessment of the Simplified Pregnancy Risk Score, a structured framework for individualized risk stratification. We followed PRISMA guidelines and searched PubMed, Scopus, Web of Science, and the Cochrane Library through August 2023 to include studies on maternal and fetal outcomes in pregnancies after living kidney donation. We used random-effects models to pool odds ratios and calculate absolute risk differences. We used subgroup and regression analyses to identify key risk modifiers that informed the development of the points-based Simplified Pregnancy Risk Score. Our search identified 15 studies encompassing 4200 pregnancies. Preeclampsia (pooled incidence 7.2%; odds ratio = 2.86; 95% CI, 1.62-5.05; absolute risk difference +4.7% ) and gestational hypertension (odds ratio = 2.53, 95% CI, 1.11-5.74)were significantly increased in donors compared with nondonors. Risk of preterm birth was modestly increased (odds ratio = 1.32; 95% CI, 1.01-1.74). Subgroup analyses identified clinically relevant effect modifiers: donors aged ≥35 years had higher odds of preeclampsia than younger donors, and a donation-to-conception interval of <2 years was associated with increased risk of preterm birth. The Simplified Pregnancy Risk Score integrated 8 evidence-based factors into a simple points-based system, categorizing donors as low (0-2 points), moderate (3-5 points), or high risk (≥6 points). The Simplified Pregnancy Risk Score represents the first structured, evidence-informed framework designed to support individualized pre-conception counseling and risk-aware antenatal management in kidney donors. Although formal validation is required, this system addresses a critical translational gap by converting population-level evidence into actionable clinical risk stratification.
- 2 February 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (2) , 332-336
Kidney Transplantation as Curative Therapy for Refractory Dialysis-induced Hypotension: A Case Report and Literature Review
- 2 February 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (2) , 332-336
Kidney Transplantation as Curative Therapy for Refractory Dialysis-induced Hypotension: A Case Report and Literature Review
- 2 February 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (2) , 337-342
Contained Colonic Perforation Following Sclerotherapy and Laparoscopic Fenestration for a Post-Transplant Lymphocele: A Case Report and Review
- 2 February 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58 (2) , 337-342
Contained Colonic Perforation Following Sclerotherapy and Laparoscopic Fenestration for a Post-Transplant Lymphocele: A Case Report and Review